Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor

Status Completed

Clinical Trial Summary

Antidepressant medicines sometimes cause sexual side effects. The purpose of this study is to determine whether the sexual dysfunction sometimes caused by selective serotonin reuptake inhibitor (SSRI) antidepressant medications can be reversed by treatment with Requip (ropinirole), a medicine which is used to treat Parkinson's Disease and restless leg syndrome.

Clinical Trial Description

A significant proportion of patients taking pharmacotherapy for treatment of depression experience sexual dysfunction at distressing levels, with reported rates varying considerably. When sexual dysfunction is assessed prospectively using structured questionnaires, high levels of dysfunction have been found. SSRIs including paroxetine, sertraline, and other medications, have been shown to have a similar frequency of sexual side effects and in a recent prospectively designed study 50% of men taking sertraline reported that they were only "slightly" (18%) or "not at all" (32%) satisfied with their sexual functioning. It is reported that sexual side effects of antidepressant treatment frequently result in noncompliance with and/or premature discontinuation of treatment. A recent study showed that the dopamine agonist Requip (Ropinirole) reduced the amount of SSRI-associated sexual dysfunction. The proposed study will utilize a placebo control group in a crossover design to determine the effect on sexual dysfunction of adding Requip (Requip CR formulation) to the patient's SSRI treatment.

30 patients experiencing sexual dysfunction attributable to SSRI treatment for depression will be entered into this study. All patients will receive 6 weeks of treatment with Ropinirole and 6 weeks with placebo in a crossover fashion. Assessments of sexual functioning and depression will be made at each visit. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Sexual Dysfunction

Clinical Trial Details

NCT number	NCT00334048
Study type	Interventional
Source	St. Luke's-Roosevelt Hospital Center
Contact
Status	Completed
Phase	Phase 4
Start date	June 2006
Completion date	September 2007

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05039775` - Clitoral Therapy Device in Alleviating Sexual Dysfunction After Genital Mutilation.	N/A
Recruiting	`NCT05380856` - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction	N/A
Not yet recruiting	`NCT05918770` - Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients	N/A
Completed	`NCT02096783` - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer	N/A
Completed	`NCT02430987` - Low Sexual Desire and Metabolic Syndrome	N/A
Completed	`NCT02837796` - Effects of Trans-Obturator Tape outside-in Versus Inside-out Procedure for Stres Urinary Incontinence	N/A
Completed	`NCT01434290` - Radiation Therapy in Treating Patients With Prostate Cancer	Phase 2
Completed	`NCT01660152` - Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery	N/A
Active, not recruiting	`NCT00981305` - Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors	Phase 3
Completed	`NCT04964895` - Sexual Quality of Patients After Bladder Cancer Cystectomy	N/A
Enrolling by invitation	`NCT05832268` - Pelvic Floor Function After Obstetric Injury to the Anal Sphincter
Completed	`NCT04066218` - Sexual Function Screening in Childhood Cancer Survivors
Not yet recruiting	`NCT05530681` - Correlation Pelvic Floor Function and Ultrasound Findings One Year After Childbirth	N/A
Recruiting	`NCT05826691` - Benign Prostate Surgery and QOL and Sexual Function
Completed	`NCT04560283` - HYDEAL-D® Application for Promoting the Restoration of Sexual Function in the Postpartum Period	Phase 4
Completed	`NCT03232801` - A Mindfulness-based Intervention for Older Women With Low Sexual Desire	N/A
Suspended	`NCT04544735` - Improving Women's Function After Pelvic Radiation	N/A
Completed	`NCT05732844` - Efficacy of the Use of Vaginal Balls for the Improvement of Urinary Incontinence and Sexual Function in Women.	N/A
Recruiting	`NCT05097469` - Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Sexual Dysfunction.	N/A
Withdrawn	`NCT01635543` - Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms